Trial Profile
A Double Blind (3rd Party Open), Randomised, Placebo Controlled, Dose Escalating Study To Investigate The Safety, Toleration, Pharmacokinetics, And Pharmacodynamics Of Multiple Inhaled Doses Of PF-03635659 In Healthy Male Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Dec 2009
Price :
$35
*
At a glance
- Drugs PF 3635659 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Pfizer
- 26 Mar 2009 New trial record